In the wake of snowballing defective product lawsuits in Pennsylvania and nationwide against the manufacturers of various transvaginal surgical mesh brands, our defective device attorneys — five of whom also are doctors — want to reiterate the dangers (as stated by the federal government) associated with this particular product.
The Food and Drug Administration released public health notifications about the many serious complications associated with surgical mesh first in 2008 and again 2011. Surgical mesh was developed to address pelvic organ prolapse and urinary incontinence.
Our law firm recently won a $12.5 million verdict against Johnson & Johnson for one of its surgical mesh products. Shortly thereafter, the U.S. Court of Appeals upheld a $2 million verdict against C.R. Bard, Inc., for one of its transvaginal mesh products.
What’s more, the FDA’s 2008 notification specifically mentions “over 1,000 reports from nine surgical mesh manufacturers of complications that were associated with surgical mesh devices.”
Among the other larger mesh manufacturers are:
- American Medical Solutions
- Boston Scientific
- Coloplast
Along with C.R. Bard and Johnson & Johnson, these companies have produced various brands of surgical mesh under several subsidiaries. Some of them have discontinued their products, but there are still roughly 500,000 surgeries performed annually using some variation of transvaginal mesh.
If you or someone you love experienced serious complications after transvaginal mesh surgery, please contact the Philadelphia, Pennsylvania offices of Kline & Specter, PC, online or by telephone for a free lawsuit consultation with one of our medical malpractice and defective medical device attorneys: 215-772-1000 or 800-243-1100.
